David V - Search Results

1

Ironing out the cross talk between FGF23 and inflammation.

David V, Francis C, Babitt JL. David V, et al. Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F1-F8. doi: 10.1152/ajprenal.00359.2016. Epub 2016 Aug 31. Am J Physiol Renal Physiol. 2017. PMID: 27582104 Free PMC article. Review.

2

Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites.

Dai B, David V, Alshayeb HM, Showkat A, Gyamlani G, Horst RL, Wall BM, Quarles LD. Dai B, et al. Among authors: david v. Kidney Int. 2012 Nov;82(10):1061-70. doi: 10.1038/ki.2012.222. Epub 2012 Jun 27. Kidney Int. 2012. PMID: 22739976 Free PMC article.

3

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.

David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M. David V, et al. Kidney Int. 2016 Jan;89(1):135-46. doi: 10.1038/ki.2015.290. Epub 2016 Jan 4. Kidney Int. 2016. PMID: 26535997 Free PMC article.

4

Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule.

Portale AA, Zhang MY, David V, Martin A, Jiao Y, Gu W, Perwad F. Portale AA, et al. Among authors: david v. PLoS One. 2015 Nov 20;10(11):e0142924. doi: 10.1371/journal.pone.0142924. eCollection 2015. PLoS One. 2015. PMID: 26588476 Free PMC article.

5

Inflammation regulates fibroblast growth factor 23 production.

Francis C, David V. Francis C, et al. Among authors: david v. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):325-32. doi: 10.1097/MNH.0000000000000232. Curr Opin Nephrol Hypertens. 2016. PMID: 27191351 Free PMC article. Review.

6

Genetic background influences cardiac phenotype in murine chronic kidney disease.

Neuburg S, Dussold C, Gerber C, Wang X, Francis C, Qi L, David V, Wolf M, Martin A. Neuburg S, et al. Among authors: david v. Nephrol Dial Transplant. 2018 Jul 1;33(7):1129-1137. doi: 10.1093/ndt/gfx332. Nephrol Dial Transplant. 2018. PMID: 29309658 Free PMC article.

7

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.

Dussold C, Gerber C, White S, Wang X, Qi L, Francis C, Capella M, Courbon G, Wang J, Li C, Feng JQ, Isakova T, Wolf M, David V, Martin A. Dussold C, et al. Among authors: david v. Bone Res. 2019 Apr 25;7:12. doi: 10.1038/s41413-019-0051-1. eCollection 2019. Bone Res. 2019. PMID: 31044094 Free PMC article.

8

Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.

Francis C, Courbon G, Gerber C, Neuburg S, Wang X, Dussold C, Capella M, Qi L, Isakova T, Mehta R, Martin A, Wolf M, David V. Francis C, et al. Among authors: david v. Kidney Int. 2019 Dec;96(6):1346-1358. doi: 10.1016/j.kint.2019.07.026. Epub 2019 Aug 30. Kidney Int. 2019. PMID: 31668632 Free PMC article.

9

Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.

Courbon G, Martinez-Calle M, David V. Courbon G, et al. Among authors: david v. Curr Opin Nephrol Hypertens. 2020 Jul;29(4):359-366. doi: 10.1097/MNH.0000000000000614. Curr Opin Nephrol Hypertens. 2020. PMID: 32452919 Free PMC article. Review.

10

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.

Courbon G, Francis C, Gerber C, Neuburg S, Wang X, Lynch E, Isakova T, Babitt JL, Wolf M, Martin A, David V. Courbon G, et al. Among authors: david v. Bone Res. 2021 Aug 2;9(1):35. doi: 10.1038/s41413-021-00154-0. Bone Res. 2021. PMID: 34334787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

817 results

Search Page